Display options
Share it on

Dig Dis Sci. 2006 Mar;51(3):618-22. doi: 10.1007/s10620-006-3180-5.

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.

Digestive diseases and sciences

D Rost, G Rudolph, P Kloeters-Plachky, A Stiehl

Affiliations

  1. Department of Medicine, University of Heidelberg, Heidelberg, Germany.

PMID: 16614977 DOI: 10.1007/s10620-006-3180-5

Abstract

In primary sclerosing cholangitis (PSC), biliary enrichment of ursodeoxycholic acid (UDCA) may represent the decisive factor for its presumable beneficial effect. Up to now it is not clear how colitis and colectomy with ileo-anal pouch affect the biliary enrichment of UDCA and the biliary bile acid composition. We determined the biliary bile acid composition in 63 patients with PSC including 7 patients with ileo-anal pouch, 31 patients with colitis, and 25 patients without colitis. No differences existed between patients with and those without colitis. In patients with colectomy and pouch at a UDCA dose of 17.7 +/- 1.6 mg/kg (n = 7), biliary UDCA represented 46.4 +/- 6.7% (mean +/- SD) of total bile acids. An increase in the dose in six pouch patients from 12.5 +/- 0.9 to 22.3 +/- 1.6 mg/kg led to a slight increase in biliary enrichment of UDCA, from 39.8 +/- 8.1 to 49.4 +/- 10.7%. In five of seven patients with ileo-anal pouch, biliary UDCA enrichment was within the normal range, and in two of seven it was permanently or intermittently abnormally low. During UDCA treatment, in pouch patients the biliary content of deoxycholic acid and lithocholic acid was reduced, whereas all other bile acids were unchanged. In a minority of patients with ileo-anal pouch, biliary enrichment of UDCA may be markedly reduced, whereas patients with colitis have a biliary UDCA enrichment not different from that of patient without colitis.

References

  1. Liver. 1993 Oct;13(5):262-9 - PubMed
  2. Hepatology. 1991 Dec;14(6):1000-7 - PubMed
  3. Gastroenterology. 1992 Mar;102(3):810-5 - PubMed
  4. Gastroenterology. 1997 Sep;113(3):884-90 - PubMed
  5. Am J Physiol. 1980 Sep;239(3):G161-6 - PubMed
  6. J Hepatol. 2002 Feb;36(2):151-6 - PubMed
  7. Cell Death Differ. 1999 Sep;6(9):842-54 - PubMed
  8. Hepatology. 1999 Feb;29(2):320-7 - PubMed
  9. J Hepatol. 1998 Jan;28(1):99-106 - PubMed
  10. Hepatology. 1989 Oct;10(4):414-9 - PubMed
  11. Gastroenterology. 1990 Feb;98(2):424-8 - PubMed
  12. J Lipid Res. 1977 May;18(3):339-62 - PubMed
  13. Gastroenterology. 1991 Jan;100(1):203-11 - PubMed
  14. Hepatology. 1992 Sep;16(3):707-14 - PubMed
  15. Hepatology. 1999 Jun;29(6):1649-54 - PubMed
  16. Hepatology. 1990 Sep;12(3 Pt 1):486-91 - PubMed
  17. Gastroenterology. 1994 May;106(5):1333-41 - PubMed
  18. Hepatology. 2004 Sep;40(3):693-8 - PubMed
  19. Dig Dis Sci. 1999 Apr;44(4):817-22 - PubMed
  20. J Pediatr. 1990 Sep;117(3):482-9 - PubMed
  21. Gastroenterology. 2001 Oct;121(4):900-7 - PubMed
  22. Gastroenterology. 1994 May;106(5):1284-90 - PubMed
  23. Gastroenterology. 1977 Nov;73(5):1131-7 - PubMed
  24. J Hepatol. 1997 Mar;26(3):560-6 - PubMed
  25. Hepatology. 1992 Jun;15(6):1043-7 - PubMed
  26. Gut. 1990 Aug;31(8):918-21 - PubMed
  27. Gastroenterology. 1979 Nov;77(5):1068-73 - PubMed
  28. Life Sci. 1982 Feb 7;30(6):515-23 - PubMed
  29. Hepatology. 1990 Nov;12(5):1206-8 - PubMed
  30. Gastroenterology. 1988 May;94(5 Pt 1):1201-6 - PubMed
  31. N Engl J Med. 1991 May 30;324(22):1548-54 - PubMed
  32. Clin Chim Acta. 1982 Aug 18;123(3):275-85 - PubMed
  33. N Engl J Med. 1997 Mar 6;336(10):691-5 - PubMed

Substances

MeSH terms

Publication Types